Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease

Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease

Palmitoylethanolamide (PEA), an endogenous lipid mediator, is emerging as a promising pharmacological agent in multiple neurodegenerative disorders for its anti-inflammatory and neuroprotective properties. However, its effects on enteric inflammation and colonic dysmotility associated with Alzheimer...

Full description

Bibliographic Details
Main Authors:	Vanessa D’Antongiovanni, Carolina Pellegrini, Luca Antonioli, Laura Benvenuti, Clelia Di Salvo, Lorenzo Flori, Rebecca Piccarducci, Simona Daniele, Alma Martelli, Vincenzo Calderone, Claudia Martini, Matteo Fornai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Pharmacology
Subjects:	alzheimer’s disease colonic dysmotility enteric glial cells enteric gliosis intestinal inflammation palmitoylethanolamide
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.748021/full

Similar Items

Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease
by: Laura Benvenuti, et al.
Published: (2020-12-01)

Prodromal Intestinal Events in Alzheimer’s Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition
by: Carolina Pellegrini, et al.
Published: (2020-05-01)

The Potential Role of Microorganisms on Enteric Nervous System Development and Disease
by: Atchariya Chanpong, et al.
Published: (2023-02-01)

Endoscopic versus Laparoscopic Full-Thickness Biopsy in the Pathological Evaluation of the Enteric Nervous System
by: Bodil Ohlsson, et al.
Published: (2018-01-01)

Recent Advances in the Management of Severe Gastrointestinal Dysmotility
by: Vasant DH, et al.
Published: (2021-05-01)

Association between enteric dysmotility and GnRH antibodies: A meta-analysis
by: Karam R. Motawea, et al.
Published: (2023-10-01)

Glial A<sub>2B</sub> Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity
by: Vanessa D’Antongiovanni, et al.
Published: (2020-05-01)

Expression of Luteinizing Hormone Receptor in the Gastrointestinal Tract in Patients with and without Dysmotility
by: Oskar Hammar, et al.
Published: (2012-12-01)

Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
by: Stefania Petrosino, et al.
Published: (2019-12-01)

Influence of Polyphenols on Adipose Tissue: Sirtuins as Pivotal Players in the Browning Process
by: Lorenzo Flori, et al.
Published: (2023-05-01)

From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson’s disease
by: Carolina Pellegrini, et al.
Published: (2021-11-01)

Potential Effects of Natural H<sub>2</sub>S-Donors in Hypertension Management
by: Eugenia Piragine, et al.
Published: (2022-04-01)

Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis
by: Eugenia Piragine, et al.
Published: (2023-03-01)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
by: Stefania Petrosino, et al.
Published: (2018-03-01)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
by: Tai-Kyung Seol, et al.
Published: (2017-10-01)

Interaction between <it>Mycobacterium tuberculosis</it>, <it>Mycobacterium bovis</it>, <it>Mycobacterium avium </it>subspecies <it>paratuberculosis </it>with the enteric glia and microglial cells
by: Cannas Sara, et al.
Published: (2011-12-01)

Enteric glial cells contribute to chronic stress-induced alterations in the intestinal microbiota and barrier in rats
by: Tong Lu, et al.
Published: (2024-02-01)

Idiopathic Slow Transit Constipation: Pathophysiology, Diagnosis, and Management
by: Luke J. Vlismas, et al.
Published: (2024-01-01)

Diagnostic Approach to Enteric Disorders in Pigs
by: Andrea Luppi, et al.
Published: (2023-01-01)

Circulating Levels of Hydrogen Sulfide (H<sub>2</sub>S) in Patients with Age-Related Diseases: A Systematic Review and Meta-Analysis
by: Eugenia Piragine, et al.
Published: (2023-06-01)

Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review
by: Maria Beatrice Passavanti, et al.
Published: (2019-01-01)

From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson’s Disease
by: Alba Montalbán-Rodríguez, et al.
Published: (2024-01-01)

Therapeutic Use of Palmitoylethanolamide as an Anti-Inflammatory and Immunomodulator
by: Maria Clara Inácio de Sá, et al.
Published: (2023-12-01)

The Enteric Glia and Its Modulation by the Endocannabinoid System, a New Target for Cannabinoid-Based Nutraceuticals?
by: Laura López-Gómez, et al.
Published: (2022-10-01)

Aberrant Development of Enteric Glial Cells in the Colon of Hirschsprung's Disease
by: Tingting Zhou, et al.
Published: (2021-11-01)

Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse
by: Fiorentina Roviezzo, et al.
Published: (2017-12-01)

Enteric Glial Cells in Immunological Disorders of the Gut
by: Chang Liu, et al.
Published: (2022-04-01)

Clinical utility of Gastric Alimetry® in the management of intestinal failure patients with possible underlying gut motility disorders
by: Chris Varghese, et al.
Published: (2023-10-01)

Role of hydrogen sulfide in endothelial dysfunction: Pathophysiology and therapeutic approaches
by: Valentina Citi, et al.
Published: (2021-01-01)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
by: Stochino Loi E, et al.
Published: (2019-08-01)

Involvement of Enteric Glia in Small Intestine Neuromuscular Dysfunction of Toll-Like Receptor 4-Deficient Mice
by: Silvia Cerantola, et al.
Published: (2020-03-01)

Administration of palmitoylethanolamide in combination with topiramate in the preventive treatment of nummular headache
by: Chirchiglia D, et al.
Published: (2016-07-01)

Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study
by: Amanda Rao, et al.
Published: (2021-09-01)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
by: Ramona D’Amico, et al.
Published: (2020-07-01)

Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia
by: Lucas D. Udovin, et al.
Published: (2020-01-01)

Effects of the glial modulator palmitoylethanolamide on chronic pain intensity and brain function
by: Alshelh Z, et al.
Published: (2019-08-01)

Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications
by: Marta Valenza, et al.
Published: (2022-08-01)

The Efficacy of Palmitoylethanolamide (Levagen+) on the Incidence and Symptoms of Upper Respiratory Tract Infection—A Double Blind, Randomised, Placebo-Controlled Trial
by: Amanda Rao, et al.
Published: (2023-10-01)

Novel Insights on the Toxicity of Phycotoxins on the Gut through the Targeting of Enteric Glial Cells
by: Océane Reale, et al.
Published: (2019-07-01)

Dietary Supplement, Containing the Dry Extract of <i>Curcumin</i>, <i>Emblica</i> and <i>Cassia</i>, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity
by: Vanessa D’Antongiovanni, et al.
Published: (2023-03-01)